These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


324 related items for PubMed ID: 16640169

  • 1. Calcium channel blockers and coronary heart disease.
    Inzitari M, Di Bari M, Marchionni N.
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):6-15. PubMed ID: 16640169
    [Abstract] [Full Text] [Related]

  • 2. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
    Bangalore S, Parkar S, Messerli FH.
    Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
    [Abstract] [Full Text] [Related]

  • 3. Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies.
    Opie LH, Yusuf S, Kübler W.
    Prog Cardiovasc Dis; 2000 Apr; 43(2):171-96. PubMed ID: 11014332
    [Abstract] [Full Text] [Related]

  • 4. Calcium channel blockers and stroke.
    Inzitari D, Poggesi A.
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):16-30. PubMed ID: 16640170
    [Abstract] [Full Text] [Related]

  • 5. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
    Costanzo P, Perrone-Filardi P, Petretta M, Marciano C, Vassallo E, Gargiulo P, Paolillo S, Petretta A, Chiariello M.
    J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
    [Abstract] [Full Text] [Related]

  • 6. Long-term safety of antihypertensive therapy.
    Grossman E, Messerli FH.
    Prog Cardiovasc Dis; 2006 Jun; 49(1):16-25. PubMed ID: 16867847
    [Abstract] [Full Text] [Related]

  • 7. Aggressive blood pressure control and stroke prevention: role of calcium channel blockers.
    Papadopoulos DP, Papademetriou V.
    J Hypertens; 2008 May; 26(5):844-52. PubMed ID: 18398322
    [Abstract] [Full Text] [Related]

  • 8. Calcium channel blockers in hypertension. Is there still a controversy?
    Izzo JL.
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):1-5. PubMed ID: 16640168
    [Abstract] [Full Text] [Related]

  • 9. A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers.
    Bangalore S, Messerli FH.
    Int J Clin Pract; 2006 Oct; 60(10):1281-6. PubMed ID: 16942591
    [Abstract] [Full Text] [Related]

  • 10. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T.
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [Abstract] [Full Text] [Related]

  • 11. [Treatment of elderly hypertension with Ca channel blockers].
    Saito F, Kushiro T.
    Clin Calcium; 2005 Oct; 15(10):1717-25. PubMed ID: 16199919
    [Abstract] [Full Text] [Related]

  • 12. The management of hypertension in ischaemic heart disease.
    Hawkins NM, Dunn FG.
    Curr Opin Cardiol; 2006 Jul; 21(4):273-8. PubMed ID: 16755194
    [Abstract] [Full Text] [Related]

  • 13. The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.
    Sierra C, Coca A.
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1055-62. PubMed ID: 18793108
    [Abstract] [Full Text] [Related]

  • 14. Nifedipine gastrointestinal therapeutic system--hypertension management to improve cardiovascular outcomes.
    Heagerty AM.
    Int J Clin Pract; 2005 Sep; 59(9):1112-9. PubMed ID: 16115193
    [Abstract] [Full Text] [Related]

  • 15. Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects.
    Angeli F, Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Staessen JA, Porcellati C.
    Am J Hypertens; 2004 Sep; 17(9):817-22. PubMed ID: 15363825
    [Abstract] [Full Text] [Related]

  • 16. [An overview of hypertension studies with calcium antagonists].
    Kjeldsen SE, Midtbø K, Os I, Westheim A.
    Tidsskr Nor Laegeforen; 1999 May 20; 119(13):1878-82. PubMed ID: 10382332
    [Abstract] [Full Text] [Related]

  • 17. Revival of nifedipine, a dihydropyridine-based calcium blocker.
    Yamagishi S, Nakamura K.
    Med Hypotheses; 2007 May 20; 68(3):565-7. PubMed ID: 17011717
    [Abstract] [Full Text] [Related]

  • 18. Fixed-dose combinations of renin-angiotensin blocking agents with calcium channel blockers or hydrochlorothiazide in the treatment of hypertension.
    Bramlage P.
    Expert Opin Pharmacother; 2009 Aug 20; 10(11):1755-67. PubMed ID: 19538001
    [Abstract] [Full Text] [Related]

  • 19. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
    Dahlöf B, Devereux RB, Kjeldsen SE, Lyle PA, Zhang Z, Edelman JM.
    Blood Press; 2007 Aug 20; 16(1):6-12. PubMed ID: 17453746
    [Abstract] [Full Text] [Related]

  • 20. [Large scale clinical trials of calcium channel blockers on the prevention of cardiovascular diseases].
    Shimamoto K.
    Clin Calcium; 2005 Oct 20; 15(10):1609-14. PubMed ID: 16199905
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.